Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CNP 103

Next Previous
Drug Profile

CNP 103

Alternative Names: CNP-103; CNP-T1D

Latest Information Update: 28 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cour Pharmaceutical Development
  • Class Antihyperglycaemics; Polymers; Proteins
  • Mechanism of Action Immunomodulators; T cell activation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Type 1 diabetes mellitus

Most Recent Events

  • 12 May 2025 Phase-I/II clinical trials in Type 1 diabetes mellitus (In adolescents, In adults, Newly diagnosed) in USA (IV) (NCT06783309)
  • 01 Mar 2025 CNP 103 receives Fast Track designation for Type 1 diabetes mellitus [IV,Injection] (In adolescents, Newly diagnosed, In adults) in USA (COUR Pharmaceuticals pipeline, October 2025)
  • 04 Feb 2025 Cour Pharmaceutical Development plans a phase I/II trial for type 1 diabetes mellitus (In adults, In children, Late-stage disease, Newly diagnosed) in April 2025 (NCT06783309)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top